163 related articles for article (PubMed ID: 16817981)
1. A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
Sato S; Mizukami K; Asada T
Int J Neuropsychopharmacol; 2007 Apr; 10(2):281-3. PubMed ID: 16817981
[TBL] [Abstract][Full Text] [Related]
2. Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia.
Masuda Y; Akagawa Y; Hishikawa Y
Hum Psychopharmacol; 2002 Jun; 17(4):191-3. PubMed ID: 12404687
[TBL] [Abstract][Full Text] [Related]
3. Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
Takei A; Fukazawa T; Hamada T; Sohma H; Yabe I; Sasaki H; Tashiro K
Clin Neuropharmacol; 2004; 27(1):9-13. PubMed ID: 15090930
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial.
Suzuki H; Gen K
Psychogeriatrics; 2015 Mar; 15(1):32-7. PubMed ID: 25516380
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with tandospirone, a 5-HT(1A) receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats.
Uehara T; Matsuoka T; Itoh H; Sumiyoshi T
Pharmacol Biochem Behav; 2013 Nov; 113():1-6. PubMed ID: 24125783
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
Huang X; Li C; Li WH; Luo YL; Wang B; Zhang W; Gan JJ; Ji JL
Hum Psychopharmacol; 2013 Nov; 28(6):594-9. PubMed ID: 24519693
[TBL] [Abstract][Full Text] [Related]
7. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
[TBL] [Abstract][Full Text] [Related]
8. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
Hamuro A; Saito S
Psychogeriatrics; 2010 Dec; 10(4):198-200. PubMed ID: 21159055
[TBL] [Abstract][Full Text] [Related]
9. Dose-Dependent Efficacy of Tandospirone for an Oldest-Old Patient With Behavioral and Psychological Symptoms of Dementia.
Ochi S; Mori T; Iga JI; Ueno SI
J Clin Psychopharmacol; 2019; 39(2):176-178. PubMed ID: 30628997
[No Abstract] [Full Text] [Related]
10. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.
Tanaka H; Hashimoto M; Fukuhara R; Ishikawa T; Yatabe Y; Kaneda K; Yuuki S; Honda K; Matsuzaki S; Tsuyuguchi A; Hatada Y; Ikeda M
Psychogeriatrics; 2015 Dec; 15(4):242-7. PubMed ID: 25737233
[TBL] [Abstract][Full Text] [Related]
11. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M
J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report.
Takahashi T; Murata T; Wada Y
Mov Disord; 2008 Jan; 23(1):151-2. PubMed ID: 17987656
[No Abstract] [Full Text] [Related]
13. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
[TBL] [Abstract][Full Text] [Related]
14. 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
Takei A; Fukazawa T; Hamada T; Yabe I; Tashiro K
Psychiatry Clin Neurosci; 2003 Dec; 57(6):607-8. PubMed ID: 14629711
[No Abstract] [Full Text] [Related]
15. Beneficial effects of perospirone on aggressive behavior associated with dementia.
Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
[TBL] [Abstract][Full Text] [Related]
16. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
[TBL] [Abstract][Full Text] [Related]
17. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
Shimabukuro J; Awata S; Matsuoka H
Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
